Audiological Disturbances in Vitiligo
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Hadassah Medical Organization.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Hadassah Medical Organization
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00484224
First received: June 7, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine wether vitiligo patients have more audiological abmnormalities, than the healthy population.
| Condition |
|---|
|
Vitiligo Hearing Loss |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Cross-Sectional Time Perspective: Prospective |
Resource links provided by NLM:
Further study details as provided by Hadassah Medical Organization:
Eligibility| Ages Eligible for Study: | 3 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- vitligo patients under 50. healthy patients under 50 for control group
Exclusion Criteria:
- above age 50. systemic disease. exposure to loud noise in past. familial history of deafness use of autotoxuc drugs or steroids. autoimmune/metabolic/neurologic/vascular disease
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00484224
Contacts
| Contact: Arieh Ingber, Prof. | 972 2 6776366 | Arieh@hadassah.org.il |
Locations
| Israel | |
| Hadassah Medical Organization | Not yet recruiting |
| Jerusalem, Israel | |
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
| Principal Investigator: | Arieh Ingber, Prof. | Hadassah Medical Organization |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00484224 History of Changes |
| Other Study ID Numbers: | qwer1234-HMO-CTIL |
| Study First Received: | June 7, 2007 |
| Last Updated: | June 7, 2007 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Additional relevant MeSH terms:
|
Hearing Loss Deafness Vitiligo Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases Sensation Disorders |
Neurologic Manifestations Nervous System Diseases Signs and Symptoms Hypopigmentation Pigmentation Disorders Skin Diseases |
ClinicalTrials.gov processed this record on May 23, 2013